GnRH antagonists in poor responders.
Kolibianakis
Efstratios
E
Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Belgium. stratis@easynet.be
Albano
Carola
C
Zikopoulos
Konstantinos
K
Kahn
Jarl A
JA
Van Steirteghem
Andre
A
Devroey
Paul
P
D000328:Adult; D002064:Buserelin / Q000008:administration & dosage / Q000494:pharmacology; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D004624:Embryo Transfer / Q000592:standards; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000819:agonists / Q000037:antagonists & inhibitors*; D006801:Humans; D008596:Menotropins / Q000008:administration & dosage / Q000494:pharmacology; D006080:Ovarian Follicle / Q000187:drug effects* / Q000502:physiology; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D011256:Pregnancy Outcome; D018873:Pregnancy Rate; D020554:Sperm Injections, Intracytoplasmic
D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D002064:Buserelin